Profile data is unavailable for this security.
About the company
Akoya Biosciences, Inc. is a life sciences technology company delivering spatial biology solutions focused on transforming discovery, clinical research, and diagnostics. It offers single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and response to therapy. It offers a full continuum of spatial phenotyping solutions to serve the diverse needs of researchers across discovery, translational and clinical research: PhenoCode Panels and PhenoCycler, PhenoImager Fusion and PhenoImager HT Instruments. Its PhenoCycler platform provides ultra-high parameter biomarker discovery, with the ability to analyze high-plex single-cell resolution across the entire tissue sample. Its PhenoImager platform enables researchers to visualize, analyze, quantify and phenotype cells in situ, in fresh frozen or formalin-fixed paraffin-embedded (FFPE) tissue sections, and tissue microarrays (TMAs).
- Revenue in USD (TTM)93.22m
- Net income in USD-60.35m
- Incorporated2015
- Employees330.00
- LocationAkoya Biosciences Inc100 Campus Drive, 6Th FloorMARLBOROUGH 01762United StatesUSA
- Phone+1 (415) 765-6980
- Websitehttps://www.akoyabio.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sensus Healthcare Inc | 36.37m | 6.65m | 99.48m | 35.00 | 14.91 | 1.88 | 14.49 | 2.74 | 0.4072 | 0.4072 | 2.23 | 3.23 | 0.6601 | 1.10 | 2.65 | 1,039,057.00 | 12.06 | 10.29 | 13.25 | 12.14 | 60.23 | 62.85 | 18.27 | 15.29 | 8.20 | -- | 0.00 | -- | -45.20 | -1.58 | -98.00 | -- | -23.16 | -- |
| Monogram Technologies Inc | 365.00k | -11.69m | 102.71m | 28.00 | -- | 14.57 | -- | 281.41 | -0.3745 | -0.3745 | 0.0118 | 0.2224 | 0.0239 | -- | -- | 13,035.71 | -76.61 | -119.26 | -117.14 | -257.40 | 0.00 | -- | -3,203.87 | -5,045.60 | -- | -- | 0.00 | -- | -- | -- | -0.3964 | -- | -15.97 | -- |
| Edap Tms SA (ADR) | 68.99m | -21.87m | 114.33m | 307.00 | -- | 2.16 | -- | 1.66 | -0.5897 | -0.5897 | 1.86 | 1.43 | 0.6992 | 2.37 | 3.42 | 224,710.90 | -22.16 | -6.62 | -31.50 | -9.22 | 40.34 | 43.23 | -31.69 | -9.59 | 1.80 | -- | 0.0599 | -- | 9.64 | 9.05 | -622.06 | -- | 32.75 | -- |
| Myomo Inc | 21.11m | -9.45m | 114.86m | 101.00 | -- | 11.86 | -- | 5.44 | -0.2614 | -0.2614 | 0.5833 | 0.3204 | 1.43 | 3.50 | 10.13 | 209,020.40 | -64.07 | -81.78 | -101.11 | -115.27 | 67.35 | 68.50 | -44.75 | -85.76 | 1.94 | -- | 0.00 | -- | 23.70 | 51.09 | 24.00 | -- | 2.82 | -- |
| Fonar Corp | 102.72m | 10.29m | 116.77m | 561.00 | 11.75 | 0.7045 | 6.19 | 1.14 | 1.48 | 1.48 | 14.72 | 24.70 | 0.5023 | 19.99 | 1.41 | 183,098.20 | 7.16 | 8.73 | 7.40 | 9.60 | 45.55 | 48.33 | 14.26 | 16.39 | 9.16 | -- | 0.0051 | -- | 1.08 | 3.89 | -24.71 | -15.05 | 8.48 | -- |
| Harvard Bioscience, Inc. | 101.13m | -10.68m | 121.24m | 391.00 | -- | 1.80 | -- | 1.20 | -0.2471 | -0.2471 | 2.35 | 1.54 | 0.7441 | 1.64 | 6.88 | 258,631.70 | -7.86 | -3.29 | -9.44 | -3.89 | 58.39 | 56.67 | -10.56 | -4.57 | 0.9416 | -1.31 | 0.3467 | -- | -0.9573 | -1.45 | 64.11 | -- | 18.10 | -- |
| KORU Medical Systems Inc | 30.82m | -11.76m | 122.43m | 82.00 | -- | 6.54 | -- | 3.97 | -0.2574 | -0.2574 | 0.6742 | 0.4082 | 0.9737 | 2.94 | 6.50 | 375,817.30 | -37.15 | -17.60 | -43.48 | -20.29 | 62.49 | 59.44 | -38.16 | -21.70 | 3.27 | -- | 0.0195 | -- | 2.23 | 10.44 | -58.65 | -- | 11.10 | -- |
| EUDA Health Holdings Ltd | 3.71m | -8.44m | 127.86m | 106.00 | -- | -- | -- | 34.50 | -0.3685 | -0.4384 | 0.1707 | -0.3045 | 0.2752 | -- | 3.55 | 34,966.61 | -62.62 | -- | -- | -- | 22.72 | -- | -227.57 | -- | -- | -1.49 | -- | -- | -1.54 | -- | 66.17 | -- | -- | -- |
| 908 Devices Inc. | 52.69m | -37.99m | 127.88m | 230.00 | -- | 0.8173 | -- | 2.43 | -1.15 | -1.15 | 1.60 | 4.52 | 0.2511 | 1.54 | 4.95 | 229,069.60 | -18.11 | -14.16 | -20.12 | -15.35 | 52.32 | 53.02 | -72.10 | -64.25 | 4.23 | -- | 0.00 | -- | 7.21 | 17.89 | -8.45 | -- | 22.98 | -- |
| InfuSystem Holdings Inc | 129.37m | 366.00k | 134.29m | 499.00 | 402.30 | 2.51 | 10.72 | 1.04 | 0.0157 | 0.0157 | 5.99 | 2.51 | 1.22 | 10.38 | 6.44 | 259,264.50 | 0.3465 | 4.60 | 0.401 | 5.69 | 49.68 | 56.43 | 0.2829 | 4.07 | 1.64 | 1.97 | 0.3898 | 0.00 | 14.44 | 13.38 | 4,744.44 | -- | 6.01 | -- |
| Akoya Biosciences Inc | 93.22m | -60.35m | 140.58m | 330.00 | -- | 6.31 | -- | 1.51 | -1.22 | -1.22 | 1.89 | 0.4498 | 0.5605 | 1.93 | 6.34 | 282,472.70 | -36.29 | -- | -45.98 | -- | 57.57 | -- | -64.74 | -- | 1.98 | -8.00 | 0.7755 | -- | 29.09 | -- | 10.36 | -- | -- | -- |
| Acme United Corp | 192.71m | 19.45m | 154.34m | 645.00 | 8.40 | 1.48 | 6.17 | 0.8009 | 4.97 | 4.97 | 48.59 | 28.13 | 1.15 | 2.07 | 4.83 | 298,770.50 | 11.60 | 7.09 | 13.79 | 8.29 | 39.40 | 35.72 | 10.09 | 5.50 | 1.77 | 6.60 | 0.2621 | 18.81 | -1.27 | 6.88 | 486.31 | 31.08 | 9.02 | 4.84 |
| Stereotaxis Inc | 23.75m | -22.08m | 165.08m | 122.00 | -- | 14.25 | -- | 6.95 | -0.265 | -0.265 | 0.285 | 0.202 | 0.5632 | 1.14 | 5.04 | 194,639.30 | -49.21 | -25.02 | -71.93 | -34.12 | 59.28 | 67.57 | -87.38 | -41.90 | 1.53 | -- | 0.00 | -- | -4.89 | -1.82 | -12.33 | -- | 6.63 | -- |
| Semler Scientific Inc | 61.74m | 15.82m | 173.34m | 92.00 | 12.20 | 2.21 | 10.51 | 2.81 | 2.03 | 2.03 | 7.93 | 11.22 | 0.7706 | 16.26 | 9.15 | 671,097.80 | 19.74 | 38.83 | 22.00 | 44.41 | 88.67 | 90.22 | 25.62 | 32.58 | 3.66 | -- | 0.00 | -- | 20.28 | 25.98 | 43.69 | 32.64 | -0.3821 | -- |
| Electromed Inc | 54.72m | 5.15m | 175.72m | 174.00 | 35.12 | 3.94 | 29.33 | 3.21 | 0.5791 | 0.5791 | 6.17 | 5.16 | 1.12 | 3.27 | 2.25 | 314,459.80 | 10.51 | 8.64 | 12.51 | 10.09 | 76.26 | 76.26 | 9.41 | 8.06 | 5.27 | -- | 0.00 | 0.00 | 13.83 | 11.82 | 62.67 | 21.06 | -22.23 | -- |
Data as of Sep 19 2024. Currency figures normalised to Akoya Biosciences Inc's reporting currency: US Dollar USD
20.87%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Blue Water Life Science Advisors LPas of 30 Jun 2024 | 4.70m | 9.49% |
| The Vanguard Group, Inc.as of 30 Jun 2024 | 1.42m | 2.86% |
| BlackRock Fund Advisorsas of 30 Jun 2024 | 1.35m | 2.73% |
| Geode Capital Management LLCas of 30 Jun 2024 | 562.12k | 1.14% |
| SVB Wealth LLCas of 30 Jun 2024 | 515.32k | 1.04% |
| SSgA Funds Management, Inc.as of 30 Jun 2024 | 434.94k | 0.88% |
| Parkman Healthcare Partners LLCas of 30 Jun 2024 | 375.54k | 0.76% |
| Paragon JV Partners LLCas of 30 Jun 2024 | 350.00k | 0.71% |
| Polar Capital LLPas of 30 Jun 2024 | 329.76k | 0.67% |
| Schonfeld Strategic Advisors LLCas of 30 Jun 2024 | 294.34k | 0.60% |
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
